Takeda

Takeda Pharmaceuticals, a leading global pharmaceutical company, is dedicated to enhancing the health and well-being of individuals through innovative treatments. Committed to addressing the needs of patients and healthcare professionals, Takeda focuses on a wide array of therapeutic areas, including oncology, gastroenterology, neuroscience, and rare diseases. The company boasts a robust portfolio of products designed to improve patient outcomes, including notable medications like ADDERALL XR®, ENTYVIO®, and MYDAYIS®.

In addition to providing established treatments, Takeda actively invests in research and development to expand its pipeline of future therapies. The company emphasizes a purpose-driven approach, intertwining sustainability and corporate responsibility into its operations. With a vision for a brighter, healthier future, Takeda strives to foster diversity, equity, and inclusion within its workforce while remaining committed to community support through philanthropic initiatives. Explore Takeda's offerings and see how they are making a meaningful impact in the lives of patients across the United States and worldwide.